BMJ Open (Oct 2022)

Mechanical thrombectomy first versus direct angioplasty or stenting for the treatment of intracranial atherosclerotic stenosis-related large vessel occlusion: protocol for a systematic review and meta-analysis

  • Aman B Patel,
  • Wei Li,
  • Xue Wang,
  • Liqun Jiao,
  • Adam Andrew Dmytriw,
  • Qing Zhao,
  • Yao Feng,
  • Xuesong Bai,
  • Xiaoli Min,
  • Hengxiao Zhao,
  • Quanming Chen,
  • Jiaxin Zheng,
  • Xiaohong Zhao,
  • Wenbo Cao

DOI
https://doi.org/10.1136/bmjopen-2021-060136
Journal volume & issue
Vol. 12, no. 10

Abstract

Read online

Introduction Mechanical thrombectomy (MT) using stent retrievers or a direct aspiration first-pass technique has proven to yield better results over intravenous thrombolysis in treating acute ischaemic stroke caused by large vessel occlusion (LVO). However, the treatment of intracranial atherosclerotic stenosis-related LVO remains unclear and has been a critical problem in daily clinical practice, as it can cause a relatively high failure rate for MT. Whether direct angioplasty and/or stenting is clinically feasible and shows advantage in reducing delay to revascularisation with better functional outcome compared with MT with rescue angioplasty and/or stenting remains unclear. This study seeks to provide direct and practical clinical evidence for clinicians.Methods and analysis The main databases of PubMed, the Cochrane library, Embase and Web of Science will be screened for related studies published after1 January 2015. Primary outcomes include successful recanalisation and 90-day favourable outcome. Secondary outcomes include puncture to revascularisation time, vascular complication (perforation, dissection and vasospasm), intracerebral haemorrhage, hospital-related complications and 90-day mortality. The Newcastle-Ottawa Scale will be adopted to assess risk bias of observational studies. The I2 statistic will be used to assess heterogeneity.Ethics and dissemination No primary data of patients are needed. Therefore, ethics approval is unnecessary. The results of this systematic review and meta-analysis will be published in a peer-reviewed journal.PROSPERO registration number CRD42021268061.